Flexion Therapeutics, Inc. - stock earnings

Stock symbol FLXN is outdated, potentially delisted? Maybe it is available on other exchange?

FLXN Quarterly earnings

Date	Earnings	Revenue
2021Q2	-22.2 million USD	28.2 million USD
2021Q1	-28.6 million USD	24.6 million USD
2020Q4	-19.6 million USD	26.3 million USD
2020Q3	-24.6 million USD	23.7 million USD

FLXN Yearly earnings

Date	Earnings	Revenue
2020	-113.7 million USD	85.6 million USD
2019	-149.8 million USD	73.0 million USD
2018	-169.7 million USD	22.5 million USD
2017	-137.5 million USD	355000 USD

FLXN

Price: $9.12

52 week price:

4.30

13.66

Earnings Per Share: -0.76 USD

P/E Ratio: -4.78

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 18.7 million

Ebitda: -29.8 million

Market Capitalization: 455.5 million

Links:

FLXN on Yahoo Finance